These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 12093475

  • 1. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C.
    Biochem Pharmacol; 2002 Jun 01; 63(11):1989-96. PubMed ID: 12093475
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF, Koberle B, Masters JR, Kelland LR.
    Br J Cancer; 1999 Dec 01; 81(8):1294-303. PubMed ID: 10604725
    [Abstract] [Full Text] [Related]

  • 5. A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
    Hospers GA, Meijer C, de Leij L, Uges DR, Mulder NH, de Vries EG.
    Int J Cancer; 1990 Jul 15; 46(1):138-44. PubMed ID: 2163989
    [Abstract] [Full Text] [Related]

  • 6. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG.
    Br J Cancer; 1990 Jul 15; 62(1):72-7. PubMed ID: 2390486
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
    Mellish KJ, Kelland LR, Harrap KR.
    Br J Cancer; 1993 Aug 15; 68(2):240-50. PubMed ID: 8347478
    [Abstract] [Full Text] [Related]

  • 11. Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels.
    Raynaud FI, Odell DE, Kelland LR.
    Br J Cancer; 1996 Aug 15; 74(3):380-6. PubMed ID: 8695352
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ, Van Moorsel CJ, Lakerveld B, Smid K, Noordhuis P, Comijn EC, Weaver D, Willey JC, Voorn D, Van der Vijgh WJ, Pinedo HM.
    Int J Oncol; 2006 Jan 15; 28(1):237-44. PubMed ID: 16328001
    [Abstract] [Full Text] [Related]

  • 15. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA, de Vries EG, Mulder NH.
    Br J Cancer; 1990 Jan 15; 61(1):79-82. PubMed ID: 2153398
    [Abstract] [Full Text] [Related]

  • 16. Oral platinum analogue JM216, a radiosensitizer in oxic murine cells.
    van de Vaart PJ, Klaren HM, Hofland I, Begg AC.
    Int J Radiat Biol; 1997 Dec 15; 72(6):675-83. PubMed ID: 9416790
    [Abstract] [Full Text] [Related]

  • 17. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
    van Moorsel CJ, Pinedo HM, Veerman G, Bergman AM, Kuiper CM, Vermorken JB, van der Vijgh WJ, Peters GJ.
    Br J Cancer; 1999 Jun 01; 80(7):981-90. PubMed ID: 10362105
    [Abstract] [Full Text] [Related]

  • 19. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY, Rogers PM, Kelland LR.
    Clin Cancer Res; 1995 Sep 01; 1(9):981-9. PubMed ID: 9816070
    [Abstract] [Full Text] [Related]

  • 20. Specificity of platinum-DNA adduct repair.
    Chaney SG, Vaisman A.
    J Inorg Biochem; 1999 Oct 01; 77(1-2):71-81. PubMed ID: 10626357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.